Alveron Pharma
Latest round
- Seed
Last raised
- Dec 2024
Total raised
- $13M
Investors
- 5
About Alveron Pharma
Alveron Pharma, founded in 2019 in Nijmegen, Netherlands, develops therapies targeting acute neurological conditions. The company's co-founders are Alex Zwiers and Stephan Peters, while Ben Nichols serves as CEO.Alveron Pharma's core product offering is OKL-1111, a novel therapy designed for the rapid treatment of haemorrhagic stroke, particularly intracranial haemorrhage (ICH). This drug acts as a universal reversal agent that does not require prior identification of the anticoagulant used by the patient, allowing for immediate treatment in critical situations.Alveron Pharma's revenue model focuses on direct sales of OKL-1111 to healthcare institutions and providers. The company plans to establish partnerships with hospitals and emergency departments to facilitate swift distribution and implementation of the therapy. The company is also exploring expansion into additional European markets and North America.
Who invested in Alveron Pharma
5 investors across 2 rounds
See all investors in Alveron Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alveron Pharma
Who invested in Alveron Pharma?
Alveron Pharma has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alveron Pharma raised?
Alveron Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Alveron Pharma last raise money?
Alveron Pharma's most recent round on record is a Seed, in Dec 2024.
What does Alveron Pharma do?
Alveron Pharma, founded in 2019 in Nijmegen, Netherlands, develops therapies targeting acute neurological conditions.
Where is Alveron Pharma headquartered?
Alveron Pharma is headquartered in Nijmegen, Netherlands.
Which VCs invest in companies like Alveron Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back pharmaceuticals companies at Alveron Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Alveron Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.